Fidus Investment Corporation filings document a business development company’s portfolio results, distribution policy, capital structure and governance. Its 8-K reports furnish quarterly and annual operating results, net asset value measures, investment activity, repayment and realization proceeds, and base or supplemental dividend declarations.
Other disclosures cover annual meeting proxy matters, common stock registered on the Nasdaq Global Select Market, at-the-market equity distribution agreements, debt-note offerings, SPV credit facilities and related material agreements. The filings also identify the adviser relationship and formal terms for financing arrangements used to fund or manage the investment portfolio.
The filing presents a detailed schedule of FDUS’s portfolio, listing numerous non-control, non-affiliate, affiliate, and control investments across business services, information technology, healthcare, industrials, retail, and specialty distribution. Holdings span first lien and second lien debt, subordinated debt, revolving loans, preferred equity, common equity, and warrants.
Many loans carry floating interest rates based on a benchmark spread, such as spreads of S+5.00% to S+8.50%, with stated cash coupons and, in some cases, payment-in-kind (PIK) components up to 17.00%. The schedule also discloses unfunded commitments on several revolving loans and term loans, including amounts like $3,500, $3,427, and $3,126, along with specific investment and maturity dates extending into the early 2030s.
Fidus Investment Corporation reported strong first quarter 2026 results, with total investment income of $47.5 million and net investment income of $24.6 million, or $0.65 per share. Adjusted net investment income was $23.7 million, or $0.62 per share, reflecting higher interest and fee income. Net asset value was $742.0 million, or $19.55 per share, as of March 31, 2026. The board declared second quarter dividends totaling $0.62 per share, including a base dividend of $0.43 and a supplemental dividend of $0.19, payable June 29, 2026 to stockholders of record on June 16, 2026.
Fidus Investment Corporation is asking stockholders to approve two key items at its 2026 annual meeting. Investors will vote on electing two Class III directors, including CEO Edward H. Ross and independent director Raymond L. Anstiss, Jr., to terms running until the 2029 meeting.
Stockholders are also being asked to authorize Fidus, subject to board approval, to sell or otherwise issue common stock over the next year at prices below net asset value per share. Any such issuances would be capped so the cumulative number of shares sold under this authority does not exceed 25% of the then-outstanding common stock immediately prior to each sale. The record date is March 19, 2026, when 37,954,364 shares were outstanding.
Fidus Investment Corporation filed a prospectus supplement registering an at-the-market equity program to offer up to $400,000,000 of common stock under an Equity Distribution Agreement. Through December 31, 2025, the company sold 13,300,342 shares for gross proceeds of $265.2 million, leaving approximately $134.8 million available under the ATM Program.
The supplement states the company will not issue shares below then-current net asset value in connection with this offering; the NAV per share was $19.55 as of December 31, 2025 and the market close price was $18.40 on February 26, 2026. Sales agents may receive commissions up to 1.50% of gross proceeds, and the Adviser may elect to pay some or all commissions. Expected net proceeds if the remaining $134.8 million is sold are approximately $132.3 million, to be used for debt repayment, new investments and working capital.
Fidus Investment Corporation amended its existing at-the-market stock offering program, raising the maximum amount of common shares that may be sold from $300.0 million to $400.0 million.
The company may sell shares from time to time through Fidus Investment Advisors, Raymond James and B. Riley under an equity distribution agreement. As of March 2, 2026, approximately $134.8 million of common stock remained available for sale under this program.
Fidus Investment Corporation (FDUS) provides a detailed schedule of its investment portfolio, spanning non-control, non-affiliate, affiliate and control positions across business services, healthcare, information technology, manufacturing, specialty distribution and consumer services.
The holdings include first and second lien loans, subordinated debt, preferred equity, common equity, warrants and revolving credit facilities, many with double‑digit cash interest rates and maturities generally running from 2025 through 2031. Several credit facilities also show unfunded commitments, indicating additional capital available to portfolio companies under existing agreements.
Fidus Investment Corporation is soliciting proxies for its 2026 Annual Meeting of Stockholders to be held on June 10, 2026. Stockholders will vote to elect two Class III directors and on a proposal authorizing the Board to sell or otherwise issue common stock at prices below the Company’s then current net asset value per share, subject to conditions including that any such issuances in the aggregate do not exceed 25% of the Company’s outstanding common stock immediately prior to each sale and that board determinations and other statutory safeguards are met. The Board recommends a vote FOR both the director nominees and the below-NAV issuance authorization. The record date for voting is March 19, 2026.
Fidus Investment Corporation reported higher investment income for fourth-quarter and full-year 2025 while maintaining strong portfolio activity and shareholder payouts. Fourth-quarter total investment income rose to $42.2 million and net investment income was $19.6 million, or $0.53 per share. For 2025, total investment income reached $155.9 million and net investment income was $73.9 million, or $2.08 per share, as higher interest and fee income was offset by increased financing and management expenses. Net asset value was $741.9 million, or $19.55 per share, supported by a $1.3 billion portfolio spread across 97 active companies. The board declared first-quarter 2026 dividends totaling $0.52 per share, including a base dividend of $0.43 and a supplemental dividend of $0.09, continuing the company’s focus on income distributions.
Fidus Investment Corporation announced that its Board of Directors declared first quarter 2026 cash dividends consisting of a base dividend of $0.43 per share and a supplemental dividend of $0.09 per share. These dividends are payable on March 30, 2026 to stockholders of record as of March 20, 2026.
The company explains that its Board reviews estimates of taxable income available for distribution, which differ from GAAP income due to unrealized gains and losses, timing differences, and carryover of undistributed taxable income. Fidus also highlights its dividend reinvestment plan, under which dividends are automatically reinvested in additional shares unless stockholders opt to receive cash.
Fidus Investment Corporation announced that its Board of Directors declared first quarter 2026 cash dividends consisting of a base dividend of $0.43 per share and a supplemental dividend of $0.09 per share. These dividends are payable on March 30, 2026 to stockholders of record as of March 20, 2026.
The company explains that its Board reviews estimates of taxable income available for distribution, which differ from GAAP income due to unrealized gains and losses, timing differences, and carryover of undistributed taxable income. Fidus also highlights its dividend reinvestment plan, under which dividends are automatically reinvested in additional shares unless stockholders opt to receive cash.
Fidus Investment Corporation filed Supplement No. 5 to its prospectus for an at-the-market program to sell up to $300,000,000 of common stock.
From November 10, 2022 through September 30, 2025, the company sold 11,693,846 shares for $233.5 million in gross proceeds and $230.3 million net after commissions and expenses. As of November 4, 2025, approximately $64.9 million of capacity remains under the ATM program. Sales agent commissions are up to 1.50% of the offering price, and offering expenses are estimated at $1.0 million ($0.8 million incurred as of November 4, 2025). The filing also updates illustrative expense ratios for investors and presents recent trading ranges; the last reported sale price on November 4, 2025 was $20.61 per share.